Transcriptional regulation of methionine adenosyltransferase 2A by peroxisome proliferator-activated receptors in rat hepatic stellate cells
Open Access
- 23 January 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 55 (6) , 1942-1953
Abstract
Methionine adenosyltransferases (MATs) are critical enzymes that catalyze the formation of the methyl donor S -adenosyl methionine (SAM). The MAT2A gene, which encodes the catalytic subunit α2, is induced in dedifferentiated liver. We previously demonstrated that MAT2A expression is enhanced in activated hepatic stellate cells (HSCs) and that silencing this gene reduces HSC activation. In this study, we examined the molecular mechanisms responsible for the transcriptional regulation of the MAT2A gene in HSCs. We identified peroxisome proliferator-activated receptor (PPAR) response elements (PPREs) in the rat MAT2A promoter. The PPARγ agonist rosiglitazone (RSG) promoted quiescence in the activated rat HSC cell line (BSC) or culture-activated primary rat HSCs, decreased MAT2A expression and promoter activity, and enhanced PPARγ binding to MAT2A PPREs. In vivo HSC activation in bile duct–ligated rats lowered PPARγ interaction with MAT2A PPREs. Silencing PPARγ increased MAT2A transcription, whereas overexpressing it had the opposite effect, demonstrating that PPARγ negatively controls this gene. Site-directed mutagenesis of PPREs abolished PPARγ recruitment to the MAT2A promoter and its inhibitory effect on MAT2A transcription in quiescent HSCs. PPRE mutations decreased the basal promoter activity of MAT2A in activated HSCs independent of PPARγ, indicating that other factors might be involved in PPRE interaction. We identified PPARβ binding to wild-type but not to mutated PPREs in activated cells. Furthermore, silencing PPARβ inhibited MAT2A expression and promoter activity. Forced expression of MAT2A in RSG-treated HSCs lowered PPARγ and enhanced PPARβ expression, thereby promoting an activated phenotype. Conclusion: We identified PPARγ as a negative regulator of MAT2A in quiescent HSCs. A switch from quiescence to activation abolishes this control and allows PPARβ to up-regulate MAT2A transcription.Keywords
This publication has 28 references indexed in Scilit:
- Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitroThe International Journal of Biochemistry & Cell Biology, 2010
- Using TESS to Predict Transcription Factor Binding Sites in DNA SequenceCurrent Protocols in Bioinformatics, 2008
- Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Role of S‐adenosyl‐L‐methionine in liver health and injury†Hepatology, 2007
- Effect of ligand of peroxisome proliferator-activated receptor γ on the biological characters of hepatic stellate cellsWorld Journal of Gastroenterology, 2005
- Tumor necrosis factor-α inhibits peroxisome proliferator-activated receptor γ activity at a posttranslational level in hepatic stellate cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Methionine adenosyltransferase II β subunit gene expression provides a proliferative advantage in human hepatomaGastroenterology, 2003
- PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activationJournal of Lipid Research, 2003
- Experimental liver cirrhosis induced by alcohol and iron.Journal of Clinical Investigation, 1995
- Matlnd and Matlnspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence dataNucleic Acids Research, 1995